Antisense Inhibition of β 1 -Adrenergic Receptor mRNA in a Single Dose Produces a Profound and Prolonged Reduction in High Blood Pressure in Spontaneously Hypertensive Rats

Author:

Zhang Yuan Clare1,Bui Jonathan D.1,Shen Leping1,Phillips M. Ian1

Affiliation:

1. From the Department of Physiology, School of Medicine, University of Florida, Gainesville.

Abstract

Background —β-Blockers are the first line of therapy for hypertension. However, they are associated with side effects because of central nervous system (CNS) effects and β 2 -adrenergic antagonism. To overcome these problems and provide a long-term β 1 -blockade, antisense oligonucleotides against rat β 1 -adrenergic receptor (β 1 -AR) mRNA (β 1 -AS-ODN) were designed and tested for the ability to inhibit cardiac β 1 -ARs as well as lower blood pressure in spontaneously hypertensive rats (SHRs). Methods and Results —Radioligand binding assay showed that a single intravenous injection of β 1 -AS-ODN delivered in cationic liposomes significantly decreased cardiac β 1 -AR density by 30% to 50% for 18 days ( P <0.01), with no effect on β 2 -ARs. This was accompanied by marked attenuation of β 1 -AR–mediated positive inotropic response in isolated perfused hearts in vitro ( P <0.02) and in conscious SHRs monitored by telemetry in vivo ( P <0.02). Furthermore, the blood pressure of SHRs was reduced for 20 days, with a 38 mm Hg maximum drop. Heart rate was not significantly decreased. Quantitative autoradiography was performed to assess β 1 -AS-ODN effects on the CNS, which demonstrated no changes in β 1 -ARs in brain, in contrast to a significant reduction in heart and kidney ( P <0.05). For comparison with β-blockers, the effects of atenolol on cardiovascular hemodynamics were examined, which lowered blood pressure for only 10 hours and elicited appreciable bradycardia in SHRs. Conclusions —These results indicate that β 1 -AS-ODN, a novel approach to specific β 1 -blockade, has advantages over currently used β-blockers in providing a profound and prolonged reduction in blood pressure without affecting heart rate, β 2 -ARs, and the CNS. Diminished cardiac contractility resulting from less β 1 -AR expression contributes to the antihypertensive effect.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3